COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
15/07/2026
CHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026
Study in highly translatable non-human primate models demonstrate how selective PKA-II modulation in combination with levodopa improved motor benefit while reducing dyskinesia Development candidate, SB-0110, now [...]
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026
The West Little Rock practice retains its location, doctor team and range of dental services after more than 30 years in the community. Little Rock, AR, July 15, 2026 (GLOBE NEWSWIRE) -- Rainwater Drake Dental, a West [...]
Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service
15/07/2026
Deployment of 500,000 HYPE Expands Client Service and Revenue Opportunities Positions Company as Bonded-Capital Layer for Institutional HIP-3 Listing Service Offering DALLAS, July 15, 2026 (GLOBE NEWSWIRE) -- Hyperion [...]
RadioMedix Appoints Brian A. Markison to Board of Directors
15/07/2026
Leading pharmaceutical executive brings over 4 decades of commercial, M&A, and governance leadership HOUSTON, July 15, 2026 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a clinical-stage biotechnology company focused on [...]
Nadia Care Named ACAP Preferred Vendor, Scaling Community-Centered, Culturally-Informed Care to Combat the Maternal Health Crisis
15/07/2026
WASHINGTON, July 15, 2026 (GLOBE NEWSWIRE) -- Today, maternal health company Nadia Care announced its selection as a Preferred Vendor by the Association for Community Affiliated Plans (ACAP). The designation provides [...]
TobaGrown Acquires Manitoba Cannabis Extract Brands HWY 59 and Banter
15/07/2026
WINNIPEG, Manitoba, July 15, 2026 (GLOBE NEWSWIRE) -- TobaGrown Inc. is pleased to announce the acquisition of the HWY 59 and Banter cannabis brands, two of Manitoba's most recognized local names in cannabis extracts. [...]
New Research Reveals Patient Frustrations With AI: When Patients Call, They Want To Reach a Person
15/07/2026
PORTLAND, Ore., July 15, 2026 (GLOBE NEWSWIRE) -- WellReceived, a leader in healthcare reception services, has released new research revealing growing patient frustrations with AI in healthcare across the US, UK, and [...]
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
15/07/2026
First GLP-1 pill approved in the European Union for the treatment of obesity and overweight Only Wegovy ® pill demonstrates 17% * mean weight loss 1 and cardiovascular benefits Wegovy ® 7.2 mg injection in a single-dose [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 6th to 10th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total [...]
Inteleos Names First Chief Product Officer to Lead New Healthcare Innovation Division
15/07/2026
Reggie Jones joins the global nonprofit to build solutions that expand access to quality care ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- Inteleos has named Reggie Jones as its first Chief Product Officer, [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 6 au 10 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Retrieve Medical Partners With Clear to Enhance Identity Verification For The Retrieve Medical Passport
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) today announced a partnership with CLEAR, the secure identity company, to integrate CLEAR1, CLEAR's secure identity [...]
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
15/07/2026
Delivering versatility for airway procedures in a single, streamlined surgical solution Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the commercial launch of its LYNX COBLATION [...]
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026
Through the integration Samsung users will have access to health coaching and eligible Medicare beneficiaries access to Lark’s proven chronic disease management programs, at no out-of-pocket cost MOUNTAIN VIEW, Calif., [...]
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026
15/07/2026
ATHENS, Ga., July 15, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) announces that its wholly owned subsidiary Good Salt Life, Inc. (“GSL” or the “Company”) achieved significant growth across its online [...]
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Three new models for investigating mpox infection and pathogenesis identified Tonix is advancing TNX-801, a [...]
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
15/07/2026
ALLO-316 Achieved a 31% Confirmed Response Rate with the Recommended Phase 2 Regimen in Patients with Stage IV Renal Cell Carcinoma (RCC) with High CD70 Expression Single Dose of ALLO-316 Produced Durable Responses in [...]

Pages